Novartis ‘Urgently’ Working To Improve Zolgensma Access Program

‘Lottery-Style’ Scheme Has Gone Down Better Outside Europe

 
• By Francesca Bruce and Sue Sutter
  
airport runway under the sun as background
Novartis is continuing with its Zolgensma managed access program
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography